Market Cap

Molecular Partners AG Market Capitalization:

CHF123.0 Million

CHF as of Jan. 1, 2024

US$146.2 Million

business Molecular Partners AG Company Profile

Molecular Partners AG Main Stock Listing

SIX: MOLN

Market Capitalization History of Molecular Partners AG

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $461.52 B
Vertex Pharmaceuticals Incorporated $107.23 B
Regeneron Pharmaceuticals, Inc. $100.01 B
CSL Limited $94.74 B
Marinomed Biotech AG $73.23 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $586.39 B
UnitedHealth Group $504.47 B
Novo Nordisk $461.52 B
Johnson & Johnson $387.50 B
Merck $296.51 B

Yearly evolution of Molecular Partners AG market cap

Date Market Cap YoY Change
Jan. 1, 2024 CHF123.0 M -47.48%
Jan. 1, 2023 CHF234.3 M -74.49%
Jan. 1, 2022 CHF918.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Top 1-year algo backtest: +298.72%

$10,000 in April 2023 would now be $39,872 by following this algorithm daily at market close.

Boost your stocks returns with Disfold AI... Now!

Try Disfold AI for FREE

Molecular Partners AG Categories

Switzerland languages Healthcare languages Biotechnology
Switzerland Healthcare Switzerland Biotechnology

Stocks & Indices

Molecular Partners AG has the following listings and related stock indices.


Stock: SIX: MOLN

Stock: NASDAQ: MOLN

Stock: OTC: MLLCF

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.